Skip to main content
Erschienen in: Journal of Genetic Counseling 4/2014

01.08.2014 | Next Generation Genetic Counseling

Lynch Syndrome Patients’ Views of and Preferences for Return of Results Following Whole Exome Sequencing

verfasst von: Kelly Hitch, Galen Joseph, Jenna Guiltinan, Jessica Kianmahd, Janey Youngblom, Amie Blanco

Erschienen in: Journal of Genetic Counseling | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Whole exome sequencing (WES) uses next generation sequencing technology to provide information on nearly all functional, protein-coding regions in an individual’s genome. Due to the vast amount of information and incidental findings that can be generated from this technology, patient preferences must be investigated to help clinicians consent and return results to patients. Patients (n = 19) who were previously clinically diagnosed with Lynch syndrome, but received uninformative negative Lynch syndrome genetic results through traditional molecular testing methods participated in semi-structured interviews after WES testing but before return of results to explore their views of WES and preferences for return of results. Analyses of interview results found that nearly all participants believed that the benefits of receiving all possible results generated from WES outweighed the undesirable effects. The majority of participants conveyed that relative to coping with a cancer diagnosis, information generated from WES would be manageable. Importantly, participants’ experience with Lynch syndrome influenced their notions of genetic determinism, tolerance for uncertain results, and family communication plans. Participants would prefer to receive WES results in person from a genetic counselor or medical geneticist so that an expert could help explain the meaning and implications of the potentially large quantity and range of complicated results. These results underscore the need to study various populations with regard to the clinical use of WES in order to effectively and empathetically communicate the possible implications of this new technology and return results.
Literatur
Zurück zum Zitat Aktan-Collan, K., Mecklin, J. P., Jarvinen, H., Nystrom-Lahti, M., Peltomaki, P., Soderling, I., et al. (2000). Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Internal Journal of Cancer, 89(1), 44–50.CrossRef Aktan-Collan, K., Mecklin, J. P., Jarvinen, H., Nystrom-Lahti, M., Peltomaki, P., Soderling, I., et al. (2000). Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Internal Journal of Cancer, 89(1), 44–50.CrossRef
Zurück zum Zitat Berg, B. L. (2001). Qualitative research methods for the social sciences (4th ed.). Boston: Allyn and Bacon. Berg, B. L. (2001). Qualitative research methods for the social sciences (4th ed.). Boston: Allyn and Bacon.
Zurück zum Zitat Berg, J. S., Khoury, M. J., & Evans, J. P. (2011). Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge on bin at a time. Genetics in Medicine, 13(6), 499–505.PubMedCrossRef Berg, J. S., Khoury, M. J., & Evans, J. P. (2011). Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge on bin at a time. Genetics in Medicine, 13(6), 499–505.PubMedCrossRef
Zurück zum Zitat Burt, R. W., Cannon, J. A., David, D. S., Early, D. S., Ford, J. M., Giardiello, F. M., et al. (2013). National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology [Colorectal cancer screening]. Version 2.2013, NCCN.org. Burt, R. W., Cannon, J. A., David, D. S., Early, D. S., Ford, J. M., Giardiello, F. M., et al. (2013). National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology [Colorectal cancer screening]. Version 2.2013, NCCN.org.
Zurück zum Zitat Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences. U.S.A., 106, 19096–19101.CrossRef Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences. U.S.A., 106, 19096–19101.CrossRef
Zurück zum Zitat Gaff, C. L., & Bylund, C. L. (2010). Family communication about genetics: Theory and practice. New York: Oxford University Press. Gaff, C. L., & Bylund, C. L. (2010). Family communication about genetics: Theory and practice. New York: Oxford University Press.
Zurück zum Zitat Green, R. C., Berg, J. S., Berry, G. T., Biesecker, L. G., Dimmock, D. P., Evans, J. P., et al. (2012). Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genetics in Medicine, 14(4), 405–410.PubMedPubMedCentralCrossRef Green, R. C., Berg, J. S., Berry, G. T., Biesecker, L. G., Dimmock, D. P., Evans, J. P., et al. (2012). Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genetics in Medicine, 14(4), 405–410.PubMedPubMedCentralCrossRef
Zurück zum Zitat Guiltinan, J. S., Hitch, K., Hechter, E., Youngblom, J., & Blanco, A. (2013). Application of whole exome sequencing to mine for novel genes associated with Lynch syndrome. Unpublished manuscript. Guiltinan, J. S., Hitch, K., Hechter, E., Youngblom, J., & Blanco, A. (2013). Application of whole exome sequencing to mine for novel genes associated with Lynch syndrome. Unpublished manuscript.
Zurück zum Zitat Haimovich, A. D. (2011). Methods, challenges, and promise of next-generation sequencing in cancer biology. Yale Journal of Biology and Medicine, 84, 439–446.PubMedPubMedCentral Haimovich, A. D. (2011). Methods, challenges, and promise of next-generation sequencing in cancer biology. Yale Journal of Biology and Medicine, 84, 439–446.PubMedPubMedCentral
Zurück zum Zitat Ku, C. S., Cooper, D. N., Iacopetta, B., & Roukos, D. H. (2012). Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition. Clinical Genetics, 83(1), 2–6.PubMedCrossRef Ku, C. S., Cooper, D. N., Iacopetta, B., & Roukos, D. H. (2012). Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition. Clinical Genetics, 83(1), 2–6.PubMedCrossRef
Zurück zum Zitat Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., et al. (2006). Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. The Journal of the American Medical Association, 296(12), 1507–1517.PubMedCrossRef Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., et al. (2006). Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. The Journal of the American Medical Association, 296(12), 1507–1517.PubMedCrossRef
Zurück zum Zitat Schneider, K. A. (2012). Counseling about cancer: Strategies for genetic counseling. Hoboken: Wiley-Blackwell. Schneider, K. A. (2012). Counseling about cancer: Strategies for genetic counseling. Hoboken: Wiley-Blackwell.
Zurück zum Zitat Singleton, A. B. (2011). Exome sequencing: a transformative technology. Lancelet Neurology, 10, 942–946.CrossRef Singleton, A. B. (2011). Exome sequencing: a transformative technology. Lancelet Neurology, 10, 942–946.CrossRef
Zurück zum Zitat Shalowitz, D. I., & Miller, F. G. (2008). Communicating the results of clinical research to participants: Attitudes, practices, and future directions. Plos Medicine, 5(5), 714–720.CrossRef Shalowitz, D. I., & Miller, F. G. (2008). Communicating the results of clinical research to participants: Attitudes, practices, and future directions. Plos Medicine, 5(5), 714–720.CrossRef
Zurück zum Zitat Sobel, S. K., & Cowan, D. B. (2000). Impact of genetic testing for Huntington’s disease on the family system. American Journal of Medical Genetics, 90(1), 49–59.PubMedCrossRef Sobel, S. K., & Cowan, D. B. (2000). Impact of genetic testing for Huntington’s disease on the family system. American Journal of Medical Genetics, 90(1), 49–59.PubMedCrossRef
Zurück zum Zitat Tabor, H. K., Stock, J., Brazg, T., McMillin, M. J., Dent, K. M., Yu, J. H., et al. (2012). Informed consent for whole genome sequencing: A qualitative analysis of participant expectations and perceptions of risks, benefits and harms. American Journal of Medical Genetics, 158(Part A), 1310–1319.CrossRef Tabor, H. K., Stock, J., Brazg, T., McMillin, M. J., Dent, K. M., Yu, J. H., et al. (2012). Informed consent for whole genome sequencing: A qualitative analysis of participant expectations and perceptions of risks, benefits and harms. American Journal of Medical Genetics, 158(Part A), 1310–1319.CrossRef
Zurück zum Zitat Townsend, A., Adam, S., Birch, P. H., Lohn, Z., Rosseau, F., & Friedman, J. M. (2012). “I want to know what’s in Pandora’s box”: Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. American Journal of Medical Genetics, 158(Part A), 2519–2525.CrossRef Townsend, A., Adam, S., Birch, P. H., Lohn, Z., Rosseau, F., & Friedman, J. M. (2012). “I want to know what’s in Pandora’s box”: Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. American Journal of Medical Genetics, 158(Part A), 2519–2525.CrossRef
Zurück zum Zitat Uhlmann, W. R., Schuette, J. L., & Yashar, B. M. (2009). A guide to genetic counseling (2nd ed.). Hoboken: Wiley-Blackwell. Uhlmann, W. R., Schuette, J. L., & Yashar, B. M. (2009). A guide to genetic counseling (2nd ed.). Hoboken: Wiley-Blackwell.
Zurück zum Zitat Vernon, S. W., Gritz, E. R., Peterson, S. K., Perz, C. A., Marani, S., Amos, C. I., et al. (1999). Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiology, Biomarkers & Prevention, 8, 353–360. Vernon, S. W., Gritz, E. R., Peterson, S. K., Perz, C. A., Marani, S., Amos, C. I., et al. (1999). Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiology, Biomarkers & Prevention, 8, 353–360.
Zurück zum Zitat Weil, J. (2000). Psychosocial genetic counseling. New York: Oxford University Press. Weil, J. (2000). Psychosocial genetic counseling. New York: Oxford University Press.
Zurück zum Zitat Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., et al. (2011). Making a definitive diagnosis: Successful clinical application of WES in a child with intractable inflammatory bowel disease. Genetics in Medicine, 13(3), 255–262.PubMedCrossRef Worthey, E. A., Mayer, A. N., Syverson, G. D., Helbling, D., Bonacci, B. B., Decker, B., et al. (2011). Making a definitive diagnosis: Successful clinical application of WES in a child with intractable inflammatory bowel disease. Genetics in Medicine, 13(3), 255–262.PubMedCrossRef
Zurück zum Zitat Yu, J. H., Crouch, J., Jarnal, S. M., Tabor, H. K., & Bamshad, M. J. (2013). Attitudes of African Americans toward return of results from exome and whole genome sequencing. American Journal of Medical Genetics, 9999(Part A), 1–9. Yu, J. H., Crouch, J., Jarnal, S. M., Tabor, H. K., & Bamshad, M. J. (2013). Attitudes of African Americans toward return of results from exome and whole genome sequencing. American Journal of Medical Genetics, 9999(Part A), 1–9.
Metadaten
Titel
Lynch Syndrome Patients’ Views of and Preferences for Return of Results Following Whole Exome Sequencing
verfasst von
Kelly Hitch
Galen Joseph
Jenna Guiltinan
Jessica Kianmahd
Janey Youngblom
Amie Blanco
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 4/2014
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-014-9687-6

Weitere Artikel der Ausgabe 4/2014

Journal of Genetic Counseling 4/2014 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.